Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00249236
Status:
COMPLETED
Last Update Posted:
2011-01-14
First Post:
2005-11-04
Brief Title:
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Organization Data
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Class:
INDUSTRY
Study ID:
CR006064
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None